phenol has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Erianin could cause cell cycle arrest at the G2/M phase, and the expressions of p21 and p27 were up-regulated, while the expressions of CDK1 and Cyclin B1 were down-regulated." | 1.62 | Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway. ( Cai, Z; Fang, R; Shao, J; Xu, Y, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, Y | 1 |
| Fang, R | 1 |
| Shao, J | 1 |
| Cai, Z | 1 |
1 other study available for phenol and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Bibenzyls; Cell Cycle P | 2021 |